Several mechanisms have been implicated in TKI resistance in HCC, including activation of EGFR, PI3K/AKT, MAPK, and JAK/STAT3 pathways, EMT, hypoxia, cancer cell stemness and metabolic reprogramming [38, 39]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.